SOFA (n = 466) | SIRS (n = 398) | Difference (95% CI) | |
---|---|---|---|
Time to BC, h, median(IQR)a | 1.4(0.7–3.8) | 1.2(0.7–2.7) | 0.11(÷0.03–0.22) |
Time to AB, h, median(IQR)b | 4.3(2.6–7.5) | 4.2(2.6–7.5) | 0.1(÷0.5–0.4) |
Treated with AB before BC | 76(16.3) | 49(12.3) | 4.0(÷0.7–8.7) |
Positive BC, n (%)c | 65(13.9) | 38(9.5) | 4.4(0.1–8.7) |
Gram-positive bacteria, n (%) | 40(8.6) | 11(2.8) | 5.8(2.8–8.8) |
Gram-negative bacteria, n (%) | 37(7.7) | 27(6.8) | 0.9(÷2.5–4.4) |
Polymicrobial infection, n (%) | 12(2.6) | 1(0.3) | 2.3(0.8–3.8) |
Escherichia coli, n (%) | 21(4.5) | 20(5.0) | 0.5(÷2.4–3.4) |
Klebsiella pneumoniae, n (%) | 7(1.5) | 2(0.5) | 1.0(÷0.3–2.3) |
Staphylococcus aureus, n (%) | 7(1.5) | 1(0.3) | 1.2(÷0.02–2.40) |
Streptococcus pneumoniae, n (%) | 15(3.2) | 4(1.0) | 2.2(0.3–4.1) |
Otherd | 22(4.7) | 11(2.8) | 1.9(÷0.6–4.4) |
Enterobacter cloacae, n (%) | 6(1.3) | 1(0.25) | 1.05(÷0.1–2.2) |
Fungal infections, n (%) | 1(0.2) | 0 | 0.2(÷0.2–0.6) |